Clovis Oncology
CLVS
#9779
Rank
NZ$20.08 M
Marketcap
$0.14
Share price
0.00%
Change (1 day)
-94.92%
Change (1 year)

Earnings for Clovis Oncology (CLVS)

Earnings in 2022 (TTM): -NZ$0.34 Billion

According to Clovis Oncology's latest financial reports the company's current earnings are NZ$0.13 Billion. In 2021 the company made an earning of -NZ$0.4 Billion, an increase over its 2020 earnings that were of -NZ$0.6 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Clovis Oncology from 2010 to 2022

Annual earnings

Year Earnings Change
2022 (TTM) -NZ$0.34 Billion-14.92%
2021 -NZ$0.4 Billion-32.64%
2020 -NZ$0.6 Billion-9.06%
2019 -NZ$0.65 Billion7.49%
2018 -NZ$0.61 Billion4.42%
2017 -NZ$0.58 Billion-8.83%
2016 -NZ$0.64 Billion-0.4%
2015 -NZ$0.64 Billion140.82%
2014 -NZ$0.27 Billion86.64%
2013 -NZ$0.15 Billion19.53%
2012 -NZ$0.12 Billion
2010 -NZ$45.43 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
NZ$0.66 B-280.06%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$16.04 B-4,424.67%๐Ÿ‡ฌ๐Ÿ‡ง UK
-NZ$2.07 Billion 457.49%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$31.38 B-8,561.21%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$12.05 B-3,350.17%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$17.31 B-4,768.96%๐Ÿ‡บ๐Ÿ‡ธ USA